Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-029850
Filing Date
2017-05-03
Accepted
2017-05-03 21:12:37
Documents
2
Period of Report
2017-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8739
2 POA DOCUMENT poa.txt EX-24.3_721188 3921
  Complete submission text file 0001209191-17-029850.txt   14044
Mailing Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET, SUITE 304 NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Coric Vlad (Reporting) CIK: 0001704317 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38080 | Film No.: 17811530